SuperCells (SCT) and XRP (XRP) compared side by side. Over the past 1 year, XRP is ahead by 41.2 percentage points (SCT -85.9% against XRP -44.7%). Their daily returns move barely together (correlation 0.21 across 363 shared trading days). SCT has been the more volatile of the two, at 246% annualised against XRP's 65%.
SCTXRP
0.21over 363 shared trading days
Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.
| Metric | SCT | XRP |
|---|---|---|
| Max drawdown (400d) | -95.7% | -67.3% |
| Risk-adjusted return (90d) | -0.39 | 0.29 |
| Best 30 days (past year) | — | +41.9% |
| Worst 30 days (past year) | — | -47.3% |
Relative strength over 90 days: XRP outperformed SCT by 90.4% — measured on the SCT/XRP ratio, so it holds regardless of market direction.